Welltower WELL · NYSE
$234.21 -0.27% (-$0.64)
Summary
52 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 67% a year over the last 3 years.
- Analysts expect revenue to grow by 33% this fiscal year.
- Out of every 100 USD of revenue, 21 USD is left as free cash.
What to watch
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- It earns only 1.0 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 125.8 USD for 1 USD of yearly profit. Over the last five years it was 135.5 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 18% a year over 5 years. Over the last 3 years it grew by 23% a year. For the next fiscal year analysts expect revenue to grow by 33%. Earnings per share grew by 67% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 61 USD
- Sales and administration 33 USD
- Taxes and other -5.3 USD
- Net profit 11 USD
Net profit, industry median (REIT - Healthcare Facilities) 11 USD
Out of every 100 USD of revenue, 11 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.4 years of free cash flow. Its debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.31%
- Paid out of profit
- 164%
- Raised in a row
- 2 years
You receive $3.07 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 28
- Hold 8
- Sell 0
Today's price within the analysts' price targets
The average target of $258.08 is 10% above today's price. 78% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Senior Housing - Operating 81%
- Triple Net 11%
- Outpatient Medical 7.5%
By region
- UNITED STATES 73%
- UNITED KINGDOM 20%
- CANADA 6.8%
Senior Housing - Operating brings in 81% of revenue.
Segments in detail